Qisda has seen steady quarterly growth in revenue and profit this year. Chairman Peter Chen noted that while the IT and networking industries faced post-pandemic inventory adjustments over the past two years, they are expected to recover in 2024, improving over this year’s performance. Among its four main business units, healthcare is anticipated to experience significant growth, with projected revenue surpassing NT$30 billion.
At a recent investor conference, Chen shared that Qisda’s October revenue rebounded to NT$18 billion, marking an increase both from the previous month and from last year. He expects even higher figures in November, suggesting a strong Q4 performance compared to Q3. While this year’s growth has met Qisda’s original quarterly projections, Chen remarked that the growth pace has been modest and he is personally “not fully satisfied,” yet he remains optimistic about breaking free from the low growth of the past two years.
Chen highlighted that Qisda’s healthcare business is poised for a breakthrough next year. He acknowledged that China’s economic recovery post-pandemic has been slower than anticipated, affecting premium health checkups and medical aesthetics services at BenQ Hospital, which fell short of the targeted 10-20% growth. However, unlike many other hospitals in China facing operational challenges, BenQ Hospital remained profitable.
The healthcare division has maintained quarterly revenue of around NT$6 billion for six consecutive quarters. With BenQ Hospital’s IPO plans in Hong Kong entering the final stages, its listing on the capital market is expected to drive further growth. Qisda’s board has also approved an acquisition to raise its stake in NORBEL BABY (Ding Ding Pharmacy) to 40%, and the acquisition's completion is projected to accelerate the healthcare sector's growth next year.
Qisda is also actively engaged in the AI trend. Through ACE PILLAR’s extensive work in robotic arms, and with high-end servers now starting to ship, the company sees strong potential. Additionally, inventory adjustments in its communications business are nearing completion, paving the way for a positive outlook in 2024.
Qisda President Han Chou Huang commented that the IT business remains on a stable growth path, with signs of stabilization in the commercial and industrial markets, as well as the networking sector, which were previously impacted by customer inventory adjustments. Looking ahead, Qisda is committed to focusing on lean operations, investing in new ventures, and building a resilient, sustainable value chain with its suppliers to adapt to evolving climate and market conditions.
Qisda recently released its Q3 financial report, showing growth across its information technology, healthcare, and intelligent solutions sectors compared to the previous quarter. In December, 20 companies within Qisda’s healthcare group will participate in a medical technology expo, showcasing innovations in smart healthcare and AI applications. These initiatives highlight Qisda’s drive toward healthcare innovation and future growth momentum.
Resource (mandarin): 佳世達今年營收逐季成長 明年看好醫療事業爆發
